In particular, hepatic insulin resistance increases hepatic glucose production and triglyceride (TG) accumulation by impairing insulin-mediated inhibition of gluconeogenesis and by changing insulin-mediated TG metabolism, respectively, and these alterations contribute to hyperglycemia and dyslipidemia [1]. This evidence concerns the gene INS and Insulin resistance.